Edition:
United Kingdom

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

75.54USD
16 Jan 2018
Change (% chg)

$0.15 (+0.20%)
Prev Close
$75.39
Open
$76.01
Day's High
$76.38
Day's Low
$75.25
Volume
567,305
Avg. Vol
624,920
52-wk High
$76.38
52-wk Low
$52.01

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $31,180.87
Shares Outstanding(Mil.): 489.11
Dividend: 0.10
Yield (%): 0.66

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4

* ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 Source text: (http://bit.ly/2qDYvyf) Further company coverage:

08 Jan 2018

BRIEF-Zoetis Launches Vanguard CIV H3N2/H3N8 Vaccine For Canine Influenza Virus

* ZOETIS LAUNCHES VANGUARD CIV H3N2/H3N8 VACCINE FOR CANINE INFLUENZA VIRUS Source text for Eikon: Further company coverage:

12 Dec 2017

BRIEF-Zoetis Board Approves 20% Dividend Increase

* ZOETIS DECLARES FIRST QUARTER 2018 DIVIDEND; BOARD APPROVES 20% PAYMENT INCREASE

11 Dec 2017

BRIEF-Zoetis Inc Q3 earnings per share $0.61

* Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S

02 Nov 2017

BRIEF-Zoetis announces pricing of $1.25 bln of senior notes

* Zoetis Inc - ‍agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 3.000% senior notes due 2027​

05 Sep 2017

BRIEF-Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines

* Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines Source text for Eikon: Further company coverage:

31 Aug 2017

BRIEF-Anatara and Zoetis to negotiate terms of an international Detach commercial agreement

* Anatara and Zoetis to negotiate terms of an international Detach® commercial agreement Source text for Eikon: Further company coverage:

21 Aug 2017

BRIEF-Zoetis reports Q2 earnings per share $0.50

* Q2 earnings per share view $0.53 -- Thomson Reuters I/B/E/S

08 Aug 2017

BRIEF-High Court of Ireland approves acquisition of Nexvet by Zoetis Inc's unit

* High Court of Ireland has approved acquisition of Nexvet by Zoetis Inc through its unit Source text for Eikon: Further company coverage:

28 Jul 2017

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $62.07 +3.41
Bayer AG (BAYGn.DE) €104.52 --
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.40 --
Eli Lilly and Co (LLY.N) $85.29 -1.69

Earnings vs. Estimates